Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation.
Patel SS, Rybicki LA, Corrigan D, Dumont C, Bolwell B, Dean R, Figueroa P, Hanna R, Liu H, Gerds AT, Hill B, Jagadeesh D, Kalaycio M, Pohlman B, Ricci K, Sobecks R, Lu W, Hamilton BK, Majhail NS.
Patel SS, et al. Among authors: lu w.
Bone Marrow Transplant. 2019 May;54(5):775-781. doi: 10.1038/s41409-018-0380-5. Epub 2018 Oct 30.
Bone Marrow Transplant. 2019.
PMID: 30375493
Clinical Trial.